Emerging Mitral Technologies Where Are We Now? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH DALLAS, TX

Size: px
Start display at page:

Download "Emerging Mitral Technologies Where Are We Now? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH DALLAS, TX"

Transcription

1 Emerging Mitral Technologies Where Are We Now? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH DALLAS, TX

2 Conflict of Interest Disclosure Abbott Vascular- Co PI COAPT Trial Medtronic- Executive Committee APOLLO Trial Edwards Lifesciences- Co-PI PARTNER 3 Trial

3 SAVR & TAVR Volumes in US AVR +/-CABG TAVR Est Source: STS and ACC database as of January 23, 2018

4

5 Transcatheter MV Repair: Device Landscape 2018 Edge-to-edge MitraClip*** MitraFlex Coronary sinus annuloplasty Cardiac Dimensions Carillon** Cerclage annuloplasty Direct annuloplasty and basal ventriculoplasty Mitralign TAMR** Valtech Cardioband** GDS Accucinch* Millipede IRIS* MVRx ARTO* Mardil BACE* Mitraspan* Valcare Amend* Micardia encor Cardiac Implants RDS QuantumCor (RF) MV replacement MV replacement (cont) Edwards CardiAQ* MitralHeal Edwards Fortis* HT Consultant Saturn Neovasc Tiara* Lutter valve Abbott Tendyne* Transcatheter Technologies Tresillo Medtronic Intrepid* Venus HighLife* Verso MValve* Transmural Systems Caison* Other approaches NCSI NaviGate NeoChord DS 1000** St. Jude Harpoon neochords* Micro Interventional Babic chords* Valtech CardioValve Middle Peak Medical* ValveXchange St. Jude leaflet plication* MitrAssist Cardiosolutions Mitra-Spacer* Braile Quattuor Valtech Vchordal Cephea Mitralix Direct Flow Sinomed Accufit

6 Mitral Regurgitation Secondary Primary Type IIIb Type II

7 Transcatheter Mitral Valve Therapy PRIMARY MR Repair MitraClip Pascal Neochord Harpoon Adjunctive Annuloplasty Replacement (TMVR) SECONDARY MR Repair MitraClip Pascal Annuloplasty Direct Indirect Replacement (TMVR)

8 Mitral Regurgitation Secondary Primary Type IIIb Type II

9 MitraClip Approved in US for High Surgical Risk Degenerative (Primary) MR Only

10 MitraClip Therapy - Global Adoption Treating Centers 800 Patients (clinical & commercial) Over 50,000 Implant Rate 97% Functional MR 64% Degenerative MR 22% Mixed 14%

11 MitraClip Patients TVT Registry Source: STS/ACC TVT Registry Database as of January 23, Months

12 MitraClip In Hospital Mortality 5.00% 4.50% 4.00% 3.50% 3.00% 2.50% 2.00% 1.50% 1.00% 0.50% 0.00% 2.50% 2.20% 2.30% 2015 R4Q 2016 R4Q 2017 R4Q Source: STS/ACC TVT Registry Outcomes Report as of Oct 17, 2017

13

14 Mitral Interventions Edwards PASCAL Repair System PA S C AL ddles pacer lasps fieri FIM Ongoing

15 Mitral Interventions Edwards PASCAL Repair System

16 Mitral Interventions NEOCHORD Delivery Instrument Needle Leaflet Capture Verification Monitor Suture Cartridge

17 Mitral Interventions NEOCHORD Transapical access Off pump (beating heart) Echo guided Free leaflet edge, chordal implants MV repair CE Approved; U.S. Pivotal RCT Ongoing

18 Harpoon Artificial Cords

19 JACC Jan 2018

20 Mitral Regurgitation Secondary Primary Type IIIb Type II

21 Mitral Interventions Annulus MV Repair Systems Direct Annuloplasty Mitralign Valtech Cardioband Valcare AMEND Cardiac Implants Millipede Indirect Annuloplasty Carillon (coronary sinus approach) Mitral Cerclage MVRx

22 Cardioband

23 Millipede Complete Semi-rigid AV Valve Ring; Adjustable and Repositionable #1 Placement #2 Annular Attachment #3 Annular Reduction

24 Millipede Surgical Human Implants FIM Pending

25 Transcatheter MV Replacement More than 30 in development! Potential advantages (vs. repair) 1. Applicable to primary and secondary MR, regardless of anatomy or pathology 2. Ease of implantation (?) 3. Reliable elimination of MR 4. Greater durability?

26 New TMVR Systems First in Human Timelines

27 Early Feasibility Studies in US TMVR

28 Currently in Trials in US Tendyne CardiaQ Caisson Intrepid

29 Tendyne TMVR A global registry of 30 patients with symptomatic severe MR; Tendyne TMVR with procedural and 30-day outcomes Muller DWM et al. J Am Coll Cardiol 2016

30 JACC Jan 2018

31

32 Mitral Valve Disease Major Unanswered Questions Does MR need to be completely corrected? Can primary MR be corrected sufficiently by a transcatheter approach? Does correction of secondary MR improve survival or quality of life? Which is preferable for secondary MR- repair or replacement?

33 #8 New TMVR Systems

34 Fusion Imaging

35 Transcatheter Valve Therapy TAVR Mitral Tricuspid

36 Summary None of This is Ever As Easy As It Looks!

Sergio Berti Ospedale del Cuore Fondazione C.N.R. Reg Toscana Massa/Pisa

Sergio Berti Ospedale del Cuore Fondazione C.N.R. Reg Toscana Massa/Pisa Sergio Berti Ospedale del Cuore Fondazione C.N.R. Reg Toscana Massa/Pisa Prevalence of Valvular Disease The Lancet, Vol. 368, Nkomo, V. T. et al., Burden of valvular heart diseases: a population-based

More information

Transcatheter Mitral Innovations, Part II. Michael Mack, M.D. Baylor Scott & White Health

Transcatheter Mitral Innovations, Part II. Michael Mack, M.D. Baylor Scott & White Health Transcatheter Mitral Innovations, Part II Michael Mack, M.D. Baylor Scott & White Health Conflict of Interest Disclosure Co-PI of the COAPT Trial of MitraClip sponsored by Abbott Vascular Uncompensated

More information

Transcatheter Mitral Valve Interventions: Clinical Indications. Didier TCHETCHE, MD. Clinique Pasteur, Toulouse, France.

Transcatheter Mitral Valve Interventions: Clinical Indications. Didier TCHETCHE, MD. Clinique Pasteur, Toulouse, France. Transcatheter Mitral Valve Interventions: Clinical Indications Didier TCHETCHE, MD. Clinique Pasteur, Toulouse, France. Conflicts of interest: -Consultant for Medtronic -Consultant for Cephea Anatomy of

More information

Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today?

Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today? Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today? Peter S. Fail, MD, FACC, FACP, FSCAI Director of the Cardiac Catheterization Laboratories and Interventional

More information

Update on Transcatheter Mitral Valve Repair and Replacment

Update on Transcatheter Mitral Valve Repair and Replacment Update on Transcatheter Mitral Valve Repair and Replacment Vinod H. Thourani, MD Professor of Surgery Chair, Department of Cardiac Surgery Medstar Heart and Vascular Washington Hospital Center Georgetown

More information

Percutaneous mitral valve repair/replacement. Jan Van der Heyden MD, PhD St.Antonius Hospital Nieuwegein

Percutaneous mitral valve repair/replacement. Jan Van der Heyden MD, PhD St.Antonius Hospital Nieuwegein Percutaneous mitral valve repair/replacement Jan Van der Heyden MD, PhD St.Antonius Hospital Nieuwegein Mitral Valve anatomy Difference between AoV and MV Aortic Valve Mitral Valve Transcatheter Mitral

More information

Martin B. Leon, MD. Columbia University Medical Center Cardiovascular Research Foundation New York City. 10 mins

Martin B. Leon, MD. Columbia University Medical Center Cardiovascular Research Foundation New York City. 10 mins Martin B. Leon, MD Columbia University Medical Center Cardiovascular Research Foundation New York City 10 mins Disclosure Statement of Financial Interest TVT 2017; Chicago, IL; June 14-17, 2017 Martin

More information

Transcatheter Mitral Valve for fmr: The Era of Too Many Options

Transcatheter Mitral Valve for fmr: The Era of Too Many Options Transcatheter Mitral Valve for fmr: The Era of Too Many Options Isaac George, M.D. Surgical Director, Structural Heart & Valve Center Assistant Professor of Surgery Columbia University Medical Center Disclosure

More information

Get Ready for Percutaneous Mitral Valve Approaches

Get Ready for Percutaneous Mitral Valve Approaches Get Ready for Percutaneous Mitral Valve Approaches Paul A. Grayburn, MD Baylor Scott and White Healthcare System The Heart Hospital Baylor Plano and Baylor Heart and Vascular Hospital Dallas, TX HOPE Unmet

More information

Contemporary Management of Mitral Regurgitation Tailoring Treatment to The Patient Subset & Clinical Situation

Contemporary Management of Mitral Regurgitation Tailoring Treatment to The Patient Subset & Clinical Situation Contemporary Management of Mitral Regurgitation Tailoring Treatment to The Patient Subset & Clinical Situation Hatim Al Lawati MD, FRCPC, FACC Consultant Interventional Cardiology Sultan Qaboos University

More information

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France Future Percutaneous Therapies for Mitral Valve Disease (Mitraclip,percutaneous annuloplasty and transcatheter valve implantation) Will they reach the TAVI s success? Alec Vahanian,FESC, FRCP (Edin.) Bichat

More information

SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT VS. REPAIR: COMPETITION OR SYNERGY

SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT VS. REPAIR: COMPETITION OR SYNERGY SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT VS. REPAIR: COMPETITION OR SYNERGY Michael J. Reardon, M.D. Professor of Cardiothoracic Surgery Allison Family Distinguish Chair of Cardiovascular Research

More information

Truly Endoscopic Robotic mitral valve repair The new frontier

Truly Endoscopic Robotic mitral valve repair The new frontier Truly Endoscopic Robotic mitral valve repair The new frontier T. Sloane Guy, MD, MBA Associate Professor, Dir Robotic Cardiac Surgery Department of Cardiothoracic Surgery roboticheartsurgeon.com Disclaimers

More information

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines Advances in Percutaneous Mitral Valve Repair and Replacement Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando,

More information

Next Generation Therapies: Aortic, Mitral and Beyond

Next Generation Therapies: Aortic, Mitral and Beyond Next Generation Therapies: Aortic, Mitral and Beyond Scott M Lilly, MD PhD Medical (Interventional) Director, Structural Heart Program Heart Summit, Lima OH August 26 th, 2017 Next Generation Therapies:

More information

Percutaneous Mitral Valve Therapies

Percutaneous Mitral Valve Therapies Percutaneous Mitral Valve Therapies Jeffrey J. Popma, MD Director, Interventional Cardiology Clinical Services Beth Israel Deaconess Medical Center Associate Professor of Medicine Harvard Medical School

More information

Transcatheter Mitral & Tricuspid Therapies. Bernard J. Zovighian Corporate Vice President

Transcatheter Mitral & Tricuspid Therapies. Bernard J. Zovighian Corporate Vice President Transcatheter Mitral & Tricuspid Therapies Bernard J. Zovighian Corporate Vice President We Will Lead and Transform Treatment for Patients with Mitral and Tricuspid Diseases Mitral and Tricuspid Diseases

More information

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA Mitral Valve Disease Today Mitral regurgitation is the most

More information

Medical Technology. A Toolbox Will Be Needed to Treat Mitral Valve Disease: Repair and Replacement. Medical Technology. BMO Top 15 List Member

Medical Technology. A Toolbox Will Be Needed to Treat Mitral Valve Disease: Repair and Replacement. Medical Technology. BMO Top 15 List Member January 4, 2017 Medical Technology A Toolbox Will Be Needed to Treat Mitral Valve Disease: Repair and Replacement Bottom Line: In September 2015 we wrote a deep dive report on transcatheter mitral valve

More information

Percutaneous mitral annuloplasty. Francesco Maisano MD, FESC San Raffaele Hospital Milano, Italy

Percutaneous mitral annuloplasty. Francesco Maisano MD, FESC San Raffaele Hospital Milano, Italy Percutaneous mitral annuloplasty Francesco Maisano MD, FESC San Raffaele Hospital Milano, Italy Disclosure Consultant for Abbott, Medtronic, St Jude, Edwards, ValtechCardio Founder of 4Tech Surgical techniques

More information

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

More information

Mitral Valve Disease. James Hermiller, MD, FACC, FSCAI St Vincent Heart Center Indianapolis, IN

Mitral Valve Disease. James Hermiller, MD, FACC, FSCAI St Vincent Heart Center Indianapolis, IN Mitral Valve Disease James Hermiller, MD, FACC, FSCAI St Vincent Heart Center Indianapolis, IN Disclosures Affiliation/Financial Relationship Consulting Fees/Honoraria Speaker Bureau Company Abbott, BSC,

More information

Update on a Tethered Transapical Device for TMVR Vinay Badhwar, MD

Update on a Tethered Transapical Device for TMVR Vinay Badhwar, MD Update on a Tethered Transapical Device for TMVR Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery WVU Heart and Vascular Institute West Virginia

More information

LivaNova Investor Day

LivaNova Investor Day LivaNova Investor Day TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR) Paul Buckman General Manager, TMVR September 14, 2017 Safe Harbor Statement Certain statements in this presentation, other than purely

More information

Transcatheter Mitral Valve Replacement How Close Are We?

Transcatheter Mitral Valve Replacement How Close Are We? Transcatheter Mitral Valve Replacement How Close Are We? Gregory Pavlides, MD, PhD, FACC, FESC Professor of Medicine Miscia Chair of Interventional Cardiology Director, Cardiac Catheterization Laboratories,

More information

Transcatheter Mitral Valve Implantation: Techniques and Early Clinical Outcomes. Dr. T. Modine MD, PhD, MBA Heart team CHRU de Lille

Transcatheter Mitral Valve Implantation: Techniques and Early Clinical Outcomes. Dr. T. Modine MD, PhD, MBA Heart team CHRU de Lille Transcatheter Mitral Valve Implantation: Techniques and Early Clinical Outcomes Dr. T. Modine MD, PhD, MBA Heart team CHRU de Lille Speaker's name: Thomas Modine I have the following potential conflicts

More information

Cardiac surgery: where are we going? Ottavio Alfieri S.Raffaele University Hospital,Milan

Cardiac surgery: where are we going? Ottavio Alfieri S.Raffaele University Hospital,Milan Cardiac surgery: where are we going? Ottavio Alfieri S.Raffaele University Hospital,Milan Senning Lecture, Zurich, June 12 th 2015 1 Texas Heart Institute, 1970 The Pioneering Phase of Cardiac Surgery

More information

Transcatheter Valve Replacement: Current State in 2017

Transcatheter Valve Replacement: Current State in 2017 Transcatheter Valve Replacement: Current State in 2017 Marc A. Sintek MD Assistant Professor of Medicine Interventional Cardiology Cardiovascular Division Washington University in St. Louis Missouri ACP

More information

Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )

Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( ) Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast (2017-2022) By Region- North America, Europe, APAC and RoW By Country

More information

Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S.

Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S. ACC 2015 LBCT Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S. A report from the STS/ACC TVT Registry Paul Sorajja, MD, Saibal Kar, MD, Amanda Stebbins,

More information

Percutaneous mitral valve repair: current techniques and results

Percutaneous mitral valve repair: current techniques and results Percutaneous mitral valve repair: current techniques and results Ted Feldman, M.D., FSCAI, FACC Angioplasty Summit April 25-27 th th 2007 Seoul, Korea Ted Feldman MD, FACC, FSCAI Disclosure Information

More information

Development of a TMVR Device Challenge to Innovators

Development of a TMVR Device Challenge to Innovators Development of a TMVR Device Challenge to Innovators Eberhard Grube MD, FACC, FSCAI, FAPSIC University Bonn, Heart Center, Bonn, Germany Stanford Universuty, School of Medicine, Palo Alto, CA Disclosure

More information

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? David H. Adams, MD Cardiac Surgeon-in-Chief Mount Sinai Health System Marie Josée and Henry R. Kravis Professor and

More information

TrattamentoTrans-catetere dell insufficienza mitralica. Francesco Bedogni. Istituto Clinico S. Ambrogio, Milano

TrattamentoTrans-catetere dell insufficienza mitralica. Francesco Bedogni. Istituto Clinico S. Ambrogio, Milano TrattamentoTrans-catetere dell insufficienza mitralica Francesco Bedogni Severe MR Leads to Increased Hospital Admissions and Lower Survival Rates Significantly higher hospital admissions experienced by

More information

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD.

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD. My Choice For Percutaneous Mitral Valve Replacement Jose Luis Navia, MD. Disclosure Edwards Lifescienses St. Jude Medical MAQUET NaviGate Consultant, Investigator Consultant, Investigator Consultant, Investigator

More information

Mitral regurgitation (MR) is the most common

Mitral regurgitation (MR) is the most common Percutaneous Mitral Valve Replacement An overview of the transcatheter valve replacement therapies for treating mitral regurgitation. BY ANDER REGUEIRO, MD, AND JOSEP RODÉS-CABAU, MD Mitral regurgitation

More information

7 th Conference of Transcatheter Heart Valve Therapies

7 th Conference of Transcatheter Heart Valve Therapies 7 th Conference of Transcatheter Heart Valve Therapies May 18-19, 2018, Athens Hilton Athens, Greece Course Directors Stratis Pattakos MD Konstantinos Spargias MD Panos Vardas MD Co-Directors Nick Bouboulis

More information

Transcatheter Mitral and Tricuspid Therapies

Transcatheter Mitral and Tricuspid Therapies Edwards Lifesciences 2017 Investor Conference Transcatheter Mitral and Tricuspid Therapies Donald E. Bobo, Jr. Corporate Vice President, Strategy & Corporate Development Edwards is Poised to Lead the Transcatheter

More information

The Cardiac Surgeon of the Future

The Cardiac Surgeon of the Future The Cardiac Surgeon of the Future Gorav Ailawadi, MD Chief, Section of Adult Cardiac Surgery Professor, Surgery & Biomedical Engineering Director, Minimally Invasive Cardiac Surgery July 19, 2017 Disclosures

More information

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion Moderator: Joseph E. Bavaria, MD Roberts-Measey Professor of Surgery Vice Chair, Division of Cardiovascular

More information

Sutureless Mitral and Tricuspid Clamp Valves

Sutureless Mitral and Tricuspid Clamp Valves Sutureless Mitral and Tricuspid Clamp Valves Simple non-stent annular attachment Dr. Eric Berreklouw, MD PhD Daidalos Solutions B.V. Eindhoven/Son, The Netherlands Disclosures and acknowledgements Author

More information

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017 James S. Gammie, MD Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical The Houston Aortic Symposium February 2-25, 2017 Disclosure Statement of Financial Interest Within

More information

UPDATE STRUKTURELLE INTERVENTIONELLE KARDIOLOGIE

UPDATE STRUKTURELLE INTERVENTIONELLE KARDIOLOGIE SGK Herbsttagung 17 November 2016, Aarau UPDATE STRUKTURELLE INTERVENTIONELLE KARDIOLOGIE Stephan Windecker Department of Cardiology Swiss Cardiovascular Center Bern University Hospital, Switzerland WHAT

More information

TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES

TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES David WM Muller, MBBS, MD St Vincent s Hospital, Sydney On behalf of the Tendyne

More information

Update on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center

Update on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center Update on Percutaneous Therapies for Structural Heart Disease William Thomas MD Director of Structural Heart Program Tucson Medical Center NCVH 2014- Tucson Disclosure of Financial Interest Research: Stock

More information

Mitral regurgitation (MR) is the second most

Mitral regurgitation (MR) is the second most Current Options for Mitral Annuloplasty and Leaflet Repair The benefits and limitations of today s FDA- and CE Mark approved mitral repair technologies. BY ROBERT SCHUELER, MD, AND JAN-MALTE SINNING, MD,

More information

Prognostic Impact of FMR

Prognostic Impact of FMR Secondary Mitral Valve Regurgitation in Heart Failure, Age 60 Years From Medical Therapy to Surgical Repair to Transcatheter Intervention The Interventionalist s View Samin K Sharma, MD, FACC, FSCAI Director

More information

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification David S Rubenson MD FACC FASE Founding Director, Cardiac Non-Invasive Laboratory Scripps Clinic Medical Group number 1 Rheumatic Mitral Stenosis

More information

Transcatheter Mitral Valve Technologies: The Heart of Cardiovascular Device Innovation

Transcatheter Mitral Valve Technologies: The Heart of Cardiovascular Device Innovation Transcatheter Mitral Valve Technologies: The Heart of Cardiovascular Device Innovation MAY 2018 /// CONTRIBUTING AUTHORS Tejdeep Singh Bawa, MA Michelle Hoffmann, PhD Susan Thompson, PhD Stephanie Kwei,

More information

Current status: Percutaneous mitral valve therapy

Current status: Percutaneous mitral valve therapy Current status: Percutaneous mitral valve therapy Ted Feldman, M.D., FSCAI FACC FESC Evanston Hospital ESC Stockholm 2010 Disclosures Research Grants Abbott, Edwards Consultant Abbott, Edwards 2 Percutaneous

More information

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Device Landscape 2010 PERCUTANEOUS TECHNIQUES Percutaneous indirect annuloplasty Percutaneous direct annuloplasty Edge to Edge ( E-Valve ) Non

More information

Percutaneous Treatment of Mitral Insufficiency: Present and Future

Percutaneous Treatment of Mitral Insufficiency: Present and Future Percutaneous Treatment of Mitral Insufficiency: Present and Future Larry S. Dean, MD, MSCAI Past President SCAI Professor of Medicine and Surgery University of Washington School of Medicine Seattle, WA

More information

Choosing the Right Treatment for Primary Mitral Regurgitation ΓΡΗΓΟΡΙΟΣ ΠΑΤΤΑΚΟΣ, MD, MS Καρδιοχειρουργός Β Κ/Χ Κλινικής Αναπλ. Διευθ.

Choosing the Right Treatment for Primary Mitral Regurgitation ΓΡΗΓΟΡΙΟΣ ΠΑΤΤΑΚΟΣ, MD, MS Καρδιοχειρουργός Β Κ/Χ Κλινικής Αναπλ. Διευθ. Choosing the Right Treatment for Primary Mitral Regurgitation ΓΡΗΓΟΡΙΟΣ ΠΑΤΤΑΚΟΣ, MD, MS Καρδιοχειρουργός Β Κ/Χ Κλινικής Αναπλ. Διευθ. Διαδερμικών Βαλβίδων Δ.Θ.Κ.Α. «ΥΓΕΙΑ» Mitral Regurgitation Very common

More information

CARDIOLOGY GRAND ROUNDS

CARDIOLOGY GRAND ROUNDS CARDIOLOGY GRAND ROUNDS Title: Valvular Heart Disease at the Minneapolis Heart Institute: Practice and Innovation Speaker: Robert S. Farivar, MD, PhD Chief, Cardiothoracic Surgery, Abbott Northwestern

More information

Percutaneous Repair for MR:

Percutaneous Repair for MR: Percutaneous Repair for MR: Follow-up and longer term outcomes Ted Feldman, M.D., FSCAI FACC FESC Evanston Hospital 16th ANGIOPLASTY SUMMIT TCT Asia Pacific 2011 April 27-29 th Seoul, Korea Ted Feldman

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve

More information

Journal of the Minneapolis Heart Institute Foundation

Journal of the Minneapolis Heart Institute Foundation Journal of the Minneapolis Heart Institute Foundation Informs and educates medical professionals about leading cardiovascular research conducted by MHIF and its partners Publishes clinical research, case

More information

Advanced Mitral Valve Therapies

Advanced Mitral Valve Therapies Advanced Mitral Valve Therapies Mahesh Ramchandani MD, FRCS Chief, Section of Cardiac Surgery A Largely Untreated Patient Population Mitral Regurgitation 2009 U.S. Prevalence Total MR Patients 1,2 4,100,000

More information

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis Similarities and differences in Tricuspid vs. Mitral Valve Anatomy and Imaging. Echo evaluation

More information

Percutaneous Transcatheter Treatment of Valvular Disease TAVR and Beyond

Percutaneous Transcatheter Treatment of Valvular Disease TAVR and Beyond Percutaneous Transcatheter Treatment of Valvular Disease TAVR and Beyond CREIGHTON W. DON, MD, PHD ASSOCIATE PROFESSOR OF MEDICINE DIRECTOR, INTERVENTIONAL AND STRUCTURAL HEART FELLOWSHIPS DIVISION OF

More information

Mitral Programme Update

Mitral Programme Update Direct Flow Medical Innovations in the Aortic and Mitral Programmes Mitral Programme Update Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy Potential conflicts

More information

Durability of Mitral Valve Surgery: Repair, Replacement or simply a clip? Christoph Huber Chirurgie Cardio Vasculaire HUG

Durability of Mitral Valve Surgery: Repair, Replacement or simply a clip? Christoph Huber Chirurgie Cardio Vasculaire HUG Durability of Mitral Valve Surgery: Repair, Replacement or simply a clip? Christoph Huber Chirurgie Cardio Vasculaire HUG La chirurgie cardiaque innovatrice et durable Mitral valve disease Mitral regurgitation

More information

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC NATURAL HISTORY OF MITRAL REGURGITATION Abdallah El Sabbagh et al. JIMG 2018;11:628-643 TREATMENT OPTIONS SURGERY REPAIR REPLACEMENT PERCUTANEOUS INTERVENTIONS

More information

Percutaneous Mitral Interventions. Alec Vahanian, FESC, FRCP (Edin.) Bichat Hospital, Paris University Paris VII

Percutaneous Mitral Interventions. Alec Vahanian, FESC, FRCP (Edin.) Bichat Hospital, Paris University Paris VII Percutaneous Mitral Interventions Alec Vahanian, FESC, FRCP (Edin.) Bichat Hospital, Paris University Paris VII Rationale for Percutaneous Mitral Valve Interventions Mitral valve disease is frequent and

More information

APOLLO TMVR Trial Update: Case Presentation

APOLLO TMVR Trial Update: Case Presentation APOLLO TMVR Trial Update: Case Presentation Anelechi Anyanwu, MD, MSc, FRCS-CTh Professor and Vice-Chairman Department of Cardiovascular Surgery Icahn School of Medicine at Mount Sinai New York, NY Disclosure

More information

Repair. Commercial Products Prior authorization is recommended for Commercial Products.

Repair. Commercial Products Prior authorization is recommended for Commercial Products. Medical Coverage Policy Transcatheter Mitral Valve Repair EFFECTIVE DATE: 11 01 2018 POLICY LAST UPDATED: 06 19 2018 OVERVIEW Transcatheter mitral valve repair (TMVR) is an alternative to surgical therapy

More information

Eduardo de Marchena, M.D., F.A.C.C., F.A.C.P., F.S.C.A.I. Professor of Medicine & Surgery Associate Dean for International Medicine University of

Eduardo de Marchena, M.D., F.A.C.C., F.A.C.P., F.S.C.A.I. Professor of Medicine & Surgery Associate Dean for International Medicine University of Catheter Based Treatment of Valvular Heart Disease In the Adult Sping 2016 Eduardo de Marchena, M.D., F.A.C.C., F.A.C.P., F.S.C.A.I. Professor of Medicine & Surgery Associate Dean for International Medicine

More information

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL DISCLOSURES I WILL BE DISCUSSING OFF-LABEL USAGE OF DEVICES RELATED TO TMVR OBJECTIVES

More information

Surgeon Involvement in Transcatheter Valve Therapy

Surgeon Involvement in Transcatheter Valve Therapy Surgeon Involvement in Transcatheter Valve Therapy Prof. Hendrik Treede Mid-German Heartcenter University Hospital Halle (Saale) Once upon a time. classic interventional cardiology classic cardiac surgery

More information

Mitral valve (MV) regurgitation is common;

Mitral valve (MV) regurgitation is common; Update on Transcatheter Mitral Valve Repair A look at the current and soon-to-come transcatheter mitral valve repair options. BY DALE J. MURDOCH, MBBS; ROBERT H. BOONE, MD; ROBERT MOSS, MBBS; JOHN WEBB,

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

What Is the Role of Mitral Repair in Heart Failure?

What Is the Role of Mitral Repair in Heart Failure? ASK THE EXPERTS What Is the Role of Mitral Repair in Heart Failure? Experts discuss treatment strategies for patients with mitral regurgitation progressing to heart failure. WITH WILLIAM WEIR, MD; STEPHEN

More information

Is it Time for a National Network of Valve Centers? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH

Is it Time for a National Network of Valve Centers? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH Is it Time for a National Network of Valve Centers? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH 10 Potential Conflict of Interest Disclosure Board of Trustees American College of Cardiology Writing Committee

More information

NeoChord Mitral Valve Repair. Department of Cardiac, Thoracic and Vascular Sciences University of Padua, Italy

NeoChord Mitral Valve Repair. Department of Cardiac, Thoracic and Vascular Sciences University of Padua, Italy NeoChord Mitral Valve Repair Department of Cardiac, Thoracic and Vascular Sciences University of Padua, Italy Disclosures Proctoring for Neochord Inc. NeoChord procedure Transapical off-pump mitral valve

More information

Cite this article as:

Cite this article as: doi: 10.21037/acs.2018.10.01 Cite this article as: Beller JP, Rogers JH, Thourani VH, Ailawadi G. Early clinical results with the Tendyne transcatheter mitral valve replacement system. Ann Cardiothorac

More information

Techniques innovantes pour un ttt minimal invasif : le cas de la valve mitrale

Techniques innovantes pour un ttt minimal invasif : le cas de la valve mitrale Techniques innovantes pour un ttt minimal invasif : le cas de la valve mitrale Lyon Cardiothoracic and Vascular Surgery Department Hôpital Louis Pradel LYON France Affiliation/Financial Relationship List

More information

Early Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study

Early Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study Early Experience of Transcatheter Mitral Valve Replacement Results from the Paul Sorajja, MD for the Investigators Presenter Disclosure Information Within the past 12 months, I or my spouse/partner have

More information

Transcatheter Mitral Valve Therapies

Transcatheter Mitral Valve Therapies Outcomes and Indications of Transcatheter Mitral Valve Therapies M. Chrissoheris Attending, Department of Transcatheter Heart Valves HYGEIA, Athens 20/10/2018 Disclosures - Proctoring activities for Abbott

More information

Percutaneous Therapy for Calcific Mitral Valve Disease

Percutaneous Therapy for Calcific Mitral Valve Disease 31 st Annual State of the Art Echocardiography San Diego, CA February 18, 2018 5:00 5:15 PM 15 min Percutaneous Therapy for Calcific Mitral Valve Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive

More information

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery Techniques for ischemic mitral valve disease: An Update Conflict of Interest Disclosure Grant/ Research Support: NHLBI RO1 HL67025 Consulting Fees/Honoraria: Stanford PI PARTNER Trial, Edwards Lifesciences

More information

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions Percutaneous Tricuspid Valve Therapies: The Next Frontier? Scott M Lilly, MD PhD The Ohio State University Structural Heart Disease Course May 19 th, 2017 Outline Is the Tricuspid Valve Relevant? Data

More information

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives Bernard Iung Bichat Hospital, Paris Euro Heart Survey on Valvular Diseases 3547 Patients with Native Valve Disease n= 1250 1000

More information

Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC

Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC TAVR: When Things go Wrong Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC Disclosures Academic Echo Core Lab Abbott / St Jude Medical Edwards Medtronic

More information

Imaging to select patients for Transcatheter TV

Imaging to select patients for Transcatheter TV Imaging to select patients for Transcatheter TV Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands San Diego, february 2018 Research grants: Medtronic, Biotronik, Boston Scientific,

More information

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? Vinod H. Thourani, MD Professor of Surgery and Medicine Emory University Disclosure Statement of Financial

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Conflict of Interests

Conflict of Interests Introduction to Interventional Echocardiography Roberto M Lang, MD Tomtec Conflict of Interests Research Grants Philips Medical Imaging Research Grants Speakers bureau Advisory bureau 1 Structural Heart

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy Alan Zajarias, MD FACC Structural Interventional Fellowship Director Associate Professor Medicine Cardiovascular Division

More information

Understanding the guidelines for Interventions in MR. Ali AlMasood

Understanding the guidelines for Interventions in MR. Ali AlMasood Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe

More information

MitraClip: Why, How, and For Whom?

MitraClip: Why, How, and For Whom? MitraClip: Why, How, and For Whom? Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief, JAMA Cardiology

More information

Vinod H. Thourani, MD, FACC, FACS

Vinod H. Thourani, MD, FACC, FACS Considering SAVR in the TAVR era: Surgical Implications of TAVR Vinod H. Thourani, MD, FACC, FACS Professor of Cardiothoracic Surgery and Medicine Chief of Cardiothoracic Surgery, Emory Hospital Midtown

More information

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR Saibal Kar, MD, FACC, FAHA, FSCAI Professor of Medicine Director of Interventional Cardiac Research Smidt Heart Institute, Cedars-Sinai

More information

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI Joseph E. Bavaria, MD Roberts-Measey Professor of Surgery Vice Chair, Division of Cardiovascular Surgery University of Pennsylvania Immediate

More information

Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR)

Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR) Keynote Lecture Series Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR) Moritz C. Wyler von Ballmoos 1,2, Ankur Kalra 3, Michael

More information

Ανεπάρκεια Τριγλώχινας Επιλογή Επεμβατικής Θεραπείας. Μ. Χρυσοχέρης Τμήμα Διαδερμικών Βαλβίδων ΔΘΚΑ ΥΓΕΙΑ

Ανεπάρκεια Τριγλώχινας Επιλογή Επεμβατικής Θεραπείας. Μ. Χρυσοχέρης Τμήμα Διαδερμικών Βαλβίδων ΔΘΚΑ ΥΓΕΙΑ Ανεπάρκεια Τριγλώχινας Επιλογή Επεμβατικής Θεραπείας Μ. Χρυσοχέρης Τμήμα Διαδερμικών Βαλβίδων ΔΘΚΑ ΥΓΕΙΑ Disclosures - Proctoring activities for Abbott Vascular, Edwards Lifesciences I and the HYGEIA Hospital

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Indiana Chapter of ACC November 15 th,2008 Percutaneous Mitral Valve Repair James B Hermiller, MD, FACC The Care Group, LLC St Vincent Hospital Indianapolis, IN Mechanisms of Mitral Regurgitation Mitral

More information

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? John D. Carroll, MD Professor, Director of Interventional Cardiology and Co-Medical Director of the Cardiac and Vascular Center, University of Colorado

More information

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,

More information

Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.

Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries. Valve Surgery Total Volume 1 1 Volume 35 3 5 15 1 5 1 13 1 N = 773 5 79 15 93 1 339 In 1, surgeons performed 339 valve surgeries. surgeons have implanted more than 1, bioprosthetic aortic valves since

More information